Indi Molecular Raises $11.5M
socalTECH
JULY 7, 2017
Culver City-based Indi Molecular , a developer of protein catalyzed capture agent (PCC) biotechnology being aimed in research tools, diagnostic agents, and PET imaging, has raised $11.5M in a Series A funding. The funding was led by M Ventures (Merck Ventures BV, a subsidiary of Merck KGaA), and also included Legend Capital, Sabey Corporation, and Asset Management Ventures.
Let's personalize your content